
@article{ayd1956,
	title = {Fatal hyperpyrexia during chlorpromazine therapy},
	author = {Ayd, F. J.},
	year = {1956},
	month = {06},
	date = {1956-06},
	journal = {Journal of Clinical and Experimental Psychopathology},
	pages = {189--192},
	volume = {17},
	number = {2},
	note = {PMID: 13345882},
	langid = {eng}
}

@article{delay1960,
	title = {[A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses]},
	author = {Delay, J. and Pichot, P. and Lemperiere, T. and Elissalde, B. and Peigne, F.},
	year = {1960},
	month = {01},
	date = {1960-01},
	journal = {Annales Medico-Psychologiques},
	pages = {145--152},
	volume = {118(1)},
	note = {PMID: 13815606},
	langid = {fre}
}

@article{buckley1995,
	title = {Neuroleptic malignant syndrome.},
	author = {Buckley, P F and Hutchinson, M},
	year = {1995},
	month = {03},
	date = {1995-03-01},
	journal = {Journal of Neurology, Neurosurgery & Psychiatry},
	pages = {271--273},
	volume = {58},
	number = {3},
	doi = {10.1136/jnnp.58.3.271},
	url = {https://jnnp.bmj.com/lookup/doi/10.1136/jnnp.58.3.271},
	langid = {en}
}

@article{stetzer2016,
	title = {Neuroleptic Malignant Syndrome Due to Dopamine Agonist Withdrawal: A Reminder About the Dangers of NPO Status},
	author = {Stetzer, Rebecca and Stetzer, Rebecca},
	year = {2016},
	month = {03},
	date = {2016-03},
	journal = {Journal of the American Medical Directors Association},
	pages = {B5},
	volume = {17},
	number = {3},
	doi = {10.1016/j.jamda.2015.12.027},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S1525861015007860},
	langid = {en}
}

@article{spivak1996,
	title = {Neuroleptic malignant syndrome associated with abrupt withdrawal of anticholinergic agents},
	author = {Spivak, B. and Gonen, N. and Mester, R. and Averbuch, E. and Adlersberg, S. and Weizman, A.},
	year = {1996},
	month = {09},
	date = {1996-09},
	journal = {International Clinical Psychopharmacology},
	pages = {207--209},
	volume = {11},
	number = {3},
	doi = {10.1097/00004850-199609000-00009},
	note = {PMID: 8923101},
	langid = {eng}
}

@article{ananth2004,
	title = {Neuroleptic malignant syndrome: risk factors, pathophysiology, and treatment},
	author = {Ananth, Jambur and Aduri, Kamala and Parameswaran, Sharath and Gunatilake, Sarath},
	year = {2004},
	month = {08},
	date = {2004-08},
	journal = {Acta Neuropsychiatrica},
	pages = {219--228},
	volume = {16},
	number = {4},
	doi = {10.1111/j.0924-2708.2004.00085.x},
	url = {https://www.cambridge.org/core/product/identifier/S0924270800003902/type/journal_article},
	langid = {en}
}

@article{pollanen1998,
	title = {Unexpected death related to restraint for excited delirium: a retrospective study of deaths in police custody and in the community},
	author = {Pollanen, M. S. and Chiasson, D. A. and Cairns, J. T. and Young, J. G.},
	year = {1998},
	month = {06},
	date = {1998-06-16},
	journal = {CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne},
	pages = {1603--1607},
	volume = {158},
	number = {12},
	note = {PMID: 9645173
PMCID: PMC1229410},
	langid = {eng}
}

@article{otahbachi2010,
	title = {Excited delirium, restraints, and unexpected death: a review of pathogenesis},
	author = {Otahbachi, Mohammad and Cevik, Cihan and Bagdure, Satish and Nugent, Kenneth},
	year = {2010},
	month = {06},
	date = {2010-06},
	journal = {The American Journal of Forensic Medicine and Pathology},
	pages = {107--112},
	volume = {31},
	number = {2},
	doi = {10.1097/PAF.0b013e3181d76cdd},
	note = {PMID: 20190633},
	langid = {eng}
}

@article{tse2015,
	title = {Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective},
	author = {Tse, Lurdes and Barr, Alasdair M. and Scarapicchia, Vanessa and Vila-Rodriguez, Fidel},
	year = {2015},
	date = {2015},
	journal = {Current Neuropharmacology},
	pages = {395--406},
	volume = {13},
	number = {3},
	doi = {10.2174/1570159x13999150424113345},
	note = {PMID: 26411967
PMCID: PMC4812801},
	langid = {eng}
}

@inbook{nisijima2007,
	title = {Neuroleptic malignant syndrome and serotonin syndrome},
	author = {Nisijima, Koichi and Shioda, Katsutoshi and Iwamura, Tatsunori},
	year = {2007},
	date = {2007},
	publisher = {Elsevier},
	pages = {81--104},
	volume = {162},
	doi = {10.1016/S0079-6123(06)62006-2},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0079612306620062},
	note = {DOI: 10.1016/S0079-6123(06)62006-2},
	langid = {en}
}

@article{desai2021,
	title = {Malignant Catatonia Versus Neuroleptic Malignant Syndrome},
	author = {Desai, Saral and Hirachan, Tinu and Toma, Anca and Gerolemou, Adela},
	year = {2021},
	month = {06},
	date = {2021-06},
	journal = {Cureus},
	pages = {e15818},
	volume = {13},
	number = {6},
	doi = {10.7759/cureus.15818},
	note = {PMID: 34306883
PMCID: PMC8295452},
	langid = {eng}
}

@article{tanii1996,
	title = {Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level},
	author = {Tanii, H. and Taniguchi, N. and Niigawa, H. and Hosono, T. and Ikura, Y. and Sakamoto, S. and Kudo, T. and Nishimura, T. and Takeda, M.},
	year = {1996},
	month = {12},
	date = {1996-12-16},
	journal = {Brain Research},
	pages = {263--270},
	volume = {743},
	number = {1-2},
	doi = {10.1016/s0006-8993(96)01059-1},
	note = {PMID: 9017254},
	langid = {eng}
}

@article{nierenberg1991,
	title = {Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome},
	author = {Nierenberg, D. and Disch, M. and Manheimer, E. and Patterson, J. and Ross, J. and Silvestri, G. and Summerhill, E.},
	year = {1991},
	month = {11},
	date = {1991-11},
	journal = {Clinical Pharmacology and Therapeutics},
	pages = {580--586},
	volume = {50},
	number = {5 Pt 1},
	doi = {10.1038/clpt.1991.184},
	note = {PMID: 1934871},
	langid = {eng}
}

@article{teo2018,
	title = {Atypical Neuroleptic Malignant Syndrome Precipitated by Clozapine and Quetiapine Overdose: A Diagnostic Challenge},
	author = {Teo, David Choon Liang and Wong, Hon Khuan and Tan, Sheng Neng},
	year = {2018},
	month = {08},
	date = {2018-08},
	journal = {Innovations in Clinical Neuroscience},
	pages = {20--22},
	volume = {15},
	number = {7-8},
	note = {PMID: 30254795
PMCID: PMC6145603},
	langid = {eng}
}

@article{elkhoury2020,
	title = {Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report},
	author = {El Khoury, Rhea and Kassab, Anthony and Dagher, Ramez and Javelot, Herve and El Chammay, Rabih and Richa, Sami},
	year = {2020},
	month = {07},
	date = {2020-07},
	journal = {Journal of Psychiatric Practice},
	pages = {320--323},
	volume = {26},
	number = {4},
	doi = {10.1097/PRA.0000000000000478},
	note = {PMID: 32692129},
	langid = {eng}
}

@article{trollor2009,
	title = {Neuroleptic malignant syndrome associated with atypical antipsychotic drugs},
	author = {Trollor, Julian N. and Chen, Xiaohua and Sachdev, Perminder S.},
	year = {2009},
	date = {2009},
	journal = {CNS drugs},
	pages = {477--492},
	volume = {23},
	number = {6},
	doi = {10.2165/00023210-200923060-00003},
	note = {PMID: 19480467},
	langid = {eng}
}

@article{karagianis1999,
	title = {Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature},
	author = {Karagianis, J. L. and Phillips, L. C. and Hogan, K. P. and LeDrew, K. K.},
	year = {1999},
	month = {05},
	date = {1999-05},
	journal = {The Annals of Pharmacotherapy},
	pages = {623--630},
	volume = {33},
	number = {5},
	doi = {10.1345/aph.18286},
	note = {PMID: 10369628},
	langid = {eng}
}

@article{fleischhacker1990,
	title = {The neuroleptic malignant syndrome and its differentiation from lethal catatonia},
	author = {Fleischhacker, W. W. and Unterweger, B. and Kane, J. M. and Hinterhuber, H.},
	year = {1990},
	month = {01},
	date = {1990-01},
	journal = {Acta Psychiatrica Scandinavica},
	pages = {3--5},
	volume = {81},
	number = {1},
	doi = {10.1111/j.1600-0447.1990.tb06439.x},
	url = {https://onlinelibrary.wiley.com/doi/10.1111/j.1600-0447.1990.tb06439.x},
	langid = {en}
}

@article{fink2006,
	title = {Neuroleptic malignant syndrome is malignant catatonia, warranting treatments efficacious for catatonia},
	author = {Fink, Max and Taylor, Michael Alan},
	year = {2006},
	month = {08},
	date = {2006-08-30},
	journal = {Progress in Neuro-Psychopharmacology & Biological Psychiatry},
	volume = {30},
	number = {6},
	doi = {10.1016/j.pnpbp.2006.03.029},
	note = {PMID: 16675086},
	langid = {eng}
}

@article{tsai2005,
	title = {Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome},
	author = {Tsai, Jui-Hsiu and Yang, Pinchen and Yen, Ju-Yu and Chen, Cheng-Chung and Yang, Ming-Jen},
	year = {2005},
	month = {08},
	date = {2005-08},
	journal = {Pharmacotherapy},
	pages = {1156--1159},
	volume = {25},
	number = {8},
	doi = {10.1592/phco.2005.25.8.1156},
	note = {PMID: 16207109},
	langid = {eng}
}

@article{mathews1999,
	title = {Proposed research diagnostic criteria for neuroleptic malignant syndrome},
	author = {Mathews, Thomas and Aderibigbe, Yekeen A.},
	year = {1999},
	month = {06},
	date = {1999-06},
	journal = {The International Journal of Neuropsychopharmacology},
	pages = {129--144},
	volume = {2},
	number = {2},
	doi = {10.1017/S1461145799001388},
	note = {PMID: 11281981},
	langid = {eng}
}

@article{cronemeyer2022,
	title = {Malignant catatonia: Severity, treatment and outcome - a systematic case series analysis},
	author = {Cronemeyer, Maximilian and {Sch√∂nfeldt-Lecuona}, Carlos and Gahr, Maximilian and Keller, Ferdinand and Sartorius, Alexander},
	year = {2022},
	month = {01},
	date = {2022-01},
	journal = {The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry},
	pages = {78--86},
	volume = {23},
	number = {1},
	doi = {10.1080/15622975.2021.1925153},
	note = {PMID: 33949287},
	langid = {eng}
}

@article{racz2018,
	title = {Association Between Serotonin Syndrome and Second-Generation Antipsychotics via Pharmacological Target-Adverse Event Analysis},
	author = {Racz, Rebecca and Soldatos, Theodoros G. and Jackson, David and Burkhart, Keith},
	year = {2018},
	month = {05},
	date = {2018-05},
	journal = {Clinical and Translational Science},
	pages = {322--329},
	volume = {11},
	number = {3},
	doi = {10.1111/cts.12543},
	note = {PMID: 29575568
PMCID: PMC5944571},
	langid = {eng}
}

@article{odagaki2009,
	title = {Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics?},
	author = {Odagaki, Yuji},
	year = {2009},
	month = {01},
	date = {2009-01},
	journal = {Current Drug Safety},
	pages = {84--93},
	volume = {4},
	number = {1},
	doi = {10.2174/157488609787354387},
	note = {PMID: 19149529},
	langid = {eng}
}

@inbook{tormoehlen2018,
	title = {Neuroleptic malignant syndrome and serotonin syndrome},
	author = {Tormoehlen, Laura M. and Rusyniak, Daniel E.},
	year = {2018},
	date = {2018},
	publisher = {Elsevier},
	pages = {663--675},
	volume = {157},
	doi = {10.1016/B978-0-444-64074-1.00039-2},
	url = {https://linkinghub.elsevier.com/retrieve/pii/B9780444640741000392},
	note = {DOI: 10.1016/B978-0-444-64074-1.00039-2},
	langid = {en}
}

@article{fink1996,
	title = {Neuroleptic malignant syndrome and catatonia: one entity or two?},
	author = {Fink, M.},
	year = {1996},
	month = {01},
	date = {1996-01-01},
	journal = {Biological Psychiatry},
	pages = {1--4},
	volume = {39},
	number = {1},
	doi = {10.1016/0006-3223(95)00552-8},
	note = {PMID: 8719118},
	langid = {eng}
}

@article{francis2000,
	title = {Is Lorazepam a treatment for neuroleptic malignant syndrome?},
	author = {Francis, A. and Chandragiri, S. and Rizvi, S. and Koch, M. and Petrides, G.},
	year = {2000},
	month = {07},
	date = {2000-07},
	journal = {CNS spectrums},
	pages = {54--57},
	volume = {5},
	number = {7},
	doi = {10.1017/s1092852900013407},
	note = {PMID: 18197156},
	langid = {eng}
}

@article{yacoub2006,
	title = {Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam},
	author = {Yacoub, Adeeb and Francis, Andrew},
	year = {2006},
	month = {06},
	date = {2006-06},
	journal = {Neuropsychiatric Disease and Treatment},
	pages = {235--240},
	volume = {2},
	number = {2},
	doi = {10.2147/nedt.2006.2.2.235},
	note = {PMID: 19412469
PMCID: PMC2671780},
	langid = {eng}
}

@article{dhibjalbut1987,
	title = {Bromocriptine treatment of neuroleptic malignant syndrome},
	author = {Dhib-Jalbut, S. and Hesselbrock, R. and Mouradian, M. M. and Means, E. D.},
	year = {1987},
	month = {02},
	date = {1987-02},
	journal = {The Journal of Clinical Psychiatry},
	pages = {69--73},
	volume = {48},
	number = {2},
	note = {PMID: 3804991},
	langid = {eng}
}

@article{schvehla1988,
	title = {Neuroleptic malignant syndrome, bromocriptine, and anticholinergic drugs},
	author = {Schvehla, T. J. and Herjanic, M.},
	year = {1988},
	month = {07},
	date = {1988-07},
	journal = {The Journal of Clinical Psychiatry},
	pages = {283--284},
	volume = {49},
	number = {7},
	note = {PMID: 3391983},
	langid = {eng}
}

@article{mueller1983,
	title = {Neuroleptic Malignant Syndrome: Successful Treatment With Bromocriptine},
	author = {Mueller, Peter S.},
	year = {1983},
	month = {01},
	date = {1983-01-21},
	journal = {JAMA},
	pages = {386},
	volume = {249},
	number = {3},
	doi = {10.1001/jama.1983.03330270050032},
	url = {http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.1983.03330270050032},
	langid = {en}
}

@article{ngo2019,
	title = {Emergent Treatment of Neuroleptic Malignant Syndrome Induced by Antipsychotic Monotherapy Using Dantrolene},
	author = {Ngo, Vivian and Guerrero, Alfredo and Lanum, David and Burgett-Moreno, Michelle and Fenati, Gregory and Barr, Steven and Neeki, Michael M.},
	year = {2019},
	month = {02},
	date = {2019-02},
	journal = {Clinical Practice and Cases in Emergency Medicine},
	pages = {16--23},
	volume = {3},
	number = {1},
	doi = {10.5811/cpcem.2018.11.39667},
	note = {PMID: 30775657
PMCID: PMC6366389},
	langid = {eng}
}

@article{tsutsumi1998,
	title = {The treatment of neuroleptic malignant syndrome using dantrolene sodium: Neuroleptic malignant syndrome},
	author = {Tsutsumi, Yasuhiko and Yamamoto, Kenji and Matsuura, Shinsuke and Hata, Shunji and Sakai, Masao and Shirakura, Katsuyuki},
	year = {1998},
	month = {07},
	date = {1998-07},
	journal = {Psychiatry and Clinical Neurosciences},
	pages = {433--438},
	volume = {52},
	number = {4},
	doi = {10.1046/j.1440-1819.1998.00416.x},
	url = {http://doi.wiley.com/10.1046/j.1440-1819.1998.00416.x},
	langid = {en}
}

@article{mccarron1982,
	title = {A case of neuroleptic malignant syndrome successfully treated with amantadine},
	author = {McCarron, M. M. and Boettger, M. L. and Peck, J. J.},
	year = {1982},
	month = {09},
	date = {1982-09},
	journal = {The Journal of Clinical Psychiatry},
	pages = {381--382},
	volume = {43},
	number = {9},
	note = {PMID: 7118846},
	langid = {eng}
}

@article{kornhuber1993,
	title = {Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome},
	author = {Kornhuber, J. and Weller, M.},
	year = {1993},
	date = {1993},
	journal = {Journal of Neural Transmission. General Section},
	pages = {57--65},
	volume = {92},
	number = {1},
	doi = {10.1007/BF01245162},
	note = {PMID: 8101093},
	langid = {eng}
}

@article{weller1992,
	title = {A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndrome},
	author = {Weller, M. and Kornhuber, J.},
	year = {1992},
	month = {08},
	date = {1992-08},
	journal = {Medical Hypotheses},
	pages = {329--333},
	volume = {38},
	number = {4},
	doi = {10.1016/0306-9877(92)90027-a},
	note = {PMID: 1337136},
	langid = {eng}
}

@article{sch√∂nfeldtlecuona2020,
	title = {Treatment of the Neuroleptic Malignant Syndrome in International Therapy Guidelines: A Comparative Analysis},
	author = {{Sch√∂nfeldt-Lecuona}, Carlos and Kuhlwilm, Lilli and Cronemeyer, Maximilian and Neu, Peter and Connemann, Bernhard J. and Gahr, Maximilian and Sartorius, Alexander and {M√ºhlbauer}, Viktoria},
	year = {2020},
	month = {03},
	date = {2020-03},
	journal = {Pharmacopsychiatry},
	pages = {51--59},
	volume = {53},
	number = {2},
	doi = {10.1055/a-1046-1044},
	note = {PMID: 31820427},
	langid = {eng}
}

@article{morcos2019,
	title = {Electroconvulsive Therapy for Neuroleptic Malignant Syndrome: A Case Series},
	author = {Morcos, Nicholas and Rosinski, Amy and Maixner, Daniel F.},
	year = {2019},
	month = {12},
	date = {2019-12},
	journal = {The journal of ECT},
	pages = {225--230},
	volume = {35},
	number = {4},
	doi = {10.1097/YCT.0000000000000600},
	note = {PMID: 31764444},
	langid = {eng}
}

@article{wells1988,
	title = {Neuroleptic Rechallenge after Neuroleptic Malignant Syndrome: Case Report and Literature Review},
	author = {Wells, Amy J. and Sommi, Roger W. and Crismon, M. Lynn},
	year = {1988},
	month = {06},
	date = {1988-06},
	journal = {Drug Intelligence & Clinical Pharmacy},
	pages = {475--480},
	volume = {22},
	number = {6},
	doi = {10.1177/106002808802200606},
	url = {http://journals.sagepub.com/doi/10.1177/106002808802200606},
	langid = {en}
}

@article{kawanishi2003,
	title = {Genetic predisposition to neuroleptic malignant syndrome : implications for antipsychotic therapy},
	author = {Kawanishi, Chiaki},
	year = {2003},
	date = {2003},
	journal = {American Journal of Pharmacogenomics: Genomics-Related Research in Drug Development and Clinical Practice},
	pages = {89--95},
	volume = {3},
	number = {2},
	doi = {10.2165/00129785-200303020-00002},
	note = {PMID: 12749726},
	langid = {eng}
}

@article{rosebush1989,
	title = {Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients},
	author = {Rosebush, P. I. and Stewart, T. D. and Gelenberg, A. J.},
	year = {1989},
	month = {08},
	date = {1989-08},
	journal = {The Journal of Clinical Psychiatry},
	pages = {295--298},
	volume = {50},
	number = {8},
	note = {PMID: 2569457},
	langid = {eng}
}

@article{kane2019,
	title = {Low Incidence of Neuroleptic Malignant Syndrome Associated With Paliperidone Palmitate Long-Acting Injectable: A Database Report and Case Study},
	author = {Kane, John M. and Correll, Christoph U. and Delva, Nicholas and Gopal, Srihari and Savitz, Adam and Mathews, Maju},
	year = {2019},
	month = {04},
	date = {2019-04},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {180--182},
	volume = {39},
	number = {2},
	doi = {10.1097/JCP.0000000000001019},
	note = {PMID: 30811377
PMCID: PMC6392211},
	langid = {eng}
}

@article{misawa2021,
	title = {Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan},
	author = {Misawa, Fuminari and Okumura, Yasuyuki and Takeuchi, Yoshinori and Fujii, Yasuo and Takeuchi, Hiroyoshi},
	year = {2021},
	month = {05},
	date = {2021-05},
	journal = {Schizophrenia Research},
	pages = {42--46},
	volume = {231},
	doi = {10.1016/j.schres.2021.02.016},
	note = {PMID: 33752105},
	langid = {eng}
}

@article{langleydegroot2016,
	title = {Atypical Neuroleptic Malignant Syndrome Associated With Paliperidone Long-Acting Injection: A Case Report},
	author = {Langley-DeGroot, Michael and Joshi, Yash and Lehman, David and Rao, Sanjai},
	year = {2016},
	month = {06},
	date = {2016-06},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {277--279},
	volume = {36},
	number = {3},
	doi = {10.1097/JCP.0000000000000507},
	note = {PMID: 27043124},
	langid = {eng}
}

@article{netcheva2021,
	title = {Late-onset Neuroleptic Malignant Syndrome Associated With Paliperidone Long-acting Injection and Lithium: A Case Report},
	author = {Netcheva, Zornitza and Shin, Karen},
	year = {2021},
	month = {06},
	date = {2021-06-01},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {333--335},
	volume = {41},
	number = {3},
	doi = {10.1097/JCP.0000000000001370},
	note = {PMID: 33605644},
	langid = {eng}
}
